BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33022551)

  • 1. Can LI-RADS imaging features at gadoxetic acid-enhanced MRI predict aggressive features on pathology of single hepatocellular carcinoma?
    Wei H; Jiang H; Liu X; Qin Y; Zheng T; Liu S; Zhang X; Song B
    Eur J Radiol; 2020 Nov; 132():109312. PubMed ID: 33022551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction for Aggressiveness and Postoperative Recurrence of Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
    Lu M; Qu Q; Xu L; Zhang J; Liu M; Jiang J; Shen W; Zhang T; Zhang X
    Acad Radiol; 2023 May; 30(5):841-852. PubMed ID: 36577606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.
    Kim SS; Lee S; Kim MJ
    Eur Radiol; 2021 May; 31(5):3405-3416. PubMed ID: 33146795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
    Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
    Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma.
    Yang H; Han P; Huang M; Yue X; Wu L; Li X; Fan W; Li Q; Ma G; Lei P
    Abdom Radiol (NY); 2022 Mar; 47(3):948-956. PubMed ID: 34962593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017).
    Ding Y; Rao SX; Wang WT; Chen CZ; Li RC; Zeng M
    Cancer Imaging; 2018 Dec; 18(1):48. PubMed ID: 30526674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
    Chen J; Zhou J; Kuang S; Zhang Y; Xie S; He B; Deng Y; Yang H; Shan Q; Wu J; Sirlin CB; Wang J
    AJR Am J Roentgenol; 2019 Oct; 213(4):821-830. PubMed ID: 31120791
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.
    Ahn SJ; Kim JH; Park SJ; Kim ST; Han JK
    Abdom Radiol (NY); 2019 Feb; 44(2):539-548. PubMed ID: 30229421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI.
    Moon JY; Min JH; Kim YK; Cha D; Hwang JA; Ko SE; Choi SY; Yun EJ; Kim SW; Won HJ
    Korean J Radiol; 2021 Nov; 22(11):1786-1796. PubMed ID: 34402243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative gadoxetic acid-enhanced MRI predicts aggressive pathological features in LI-RADS category 5 hepatocellular carcinoma.
    Liang X; Shi S; Gao T
    Clin Radiol; 2022 Sep; 77(9):708-716. PubMed ID: 35738938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
    Lee S; Kim SH; Lee JE; Sinn DH; Park CK
    J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category.
    Park HJ; Kim YK; Cha DI; Ko SE; Kim S; Lee ES; Ahn S
    Clin Radiol; 2020 Jun; 75(6):478.e13-478.e23. PubMed ID: 32033745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal performance of LI-RADS v2018 on gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates.
    Oh NE; Choi SH; Kim S; Lee H; Jang HJ; Byun JH; Won HJ; Shin YM
    Eur Radiol; 2024 Jan; 34(1):465-474. PubMed ID: 37532900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corona enhancement can substitute enhancing capsule in the imaging diagnosis of small (≤ 3 cm) HCCs on gadoxetic acid-enhanced MRI.
    Ham JH; Yu JS; Choi JM; Cho ES; Kim JH; Chung JJ
    Eur Radiol; 2021 Nov; 31(11):8628-8637. PubMed ID: 33891153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
    Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
    Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence After Curative Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: Diagnostic Algorithms on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
    Wang W; Yang C; Zhu K; Yang L; Ding Y; Luo R; Zhu S; Chen C; Sun W; Zeng M; Rao SX
    Liver Transpl; 2020 Jun; 26(6):751-763. PubMed ID: 31901208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.
    Nakao S; Tanabe M; Okada M; Furukawa M; Iida E; Miyoshi K; Matsunaga N; Ito K
    Jpn J Radiol; 2019 Sep; 37(9):651-659. PubMed ID: 31321619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma: A STROBE-compliant article.
    Shin SK; Kim YS; Shim YS; Choi SJ; Park SH; Jung DH; Kwon OS; Choi DJ; Kim JH
    Medicine (Baltimore); 2017 Aug; 96(33):e7761. PubMed ID: 28816953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Imaging Reporting and Data System Category on Magnetic Resonance Imaging Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation Within the Milan Criteria: A Multicenter Study.
    Lee S; Kim KW; Jeong WK; Jeong SY; Hwang JA; Choi JS; Lee SG; Joh JW
    Ann Surg Oncol; 2021 Oct; 28(11):6782-6789. PubMed ID: 33751296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Comparison of Four Presurgical Stratifying Schemes for Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Gadoxetic Acid-Enhanced MRI.
    Sun SW; Liu QP; Xu X; Zhu FP; Zhang YD; Liu XS
    J Magn Reson Imaging; 2020 Aug; 52(2):433-447. PubMed ID: 31943465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.